Miki Stephens is the Co-Founder and COO of Tecton Ketones, a metabolic health company pioneering the use of R-3 Hydroxybutyrate Glycerides (R3HBG), a patented, bioidentical ketone molecule designed to restore metabolic flexibility and fuel cognitive and physical performance. With over 20 years of executive experience in consumer goods, healthcare innovation, and supply chain strategy, Miki brings a rare blend of operational rigor and personal conviction to her role.

After retiring in 2022, Miki was diagnosed with epilepsy, which led her to explore metabolic therapies and the history of ketones as a medical intervention for neurological conditions. Her introduction to R3HBG in 2024, and its potential to address modern metabolic dysfunction, compelled her to return to the frontlines of innovation.

Previously, Miki held senior leadership roles at Charlotte’s Web and Harmony Hemp, where she directed multi-million-dollar mergers, built nationwide retail distribution pipelines, and oversaw regulatory compliance in highly scrutinized categories. She also founded the Nexus Evolution Foundation, a nonprofit dedicated to holistic mental and metabolic health for vulnerable children.

At Tecton, Miki leads formulation research, commercialization, manufacturing, and regulatory execution, positioning ketones not as a trend but as a foundational macronutrient critical for cognition, GLP-1 health, metabolic restoration, and elite performance.